[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Peter Sicinski, M.D., Ph.D., Dana-Farber Cancer Institute

Caption: Peter Sicinski, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins that control cells' growth cycles, and to which the cancers are "addicted."

Credit: Sam Ogden

Usage Restrictions: None

Related news release: Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice


[ Back to EurekAlert! ]